I. R. Galimova
I. R. Galimova has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Evgenii Iu. Iupatov
Kazan State Medical Academy – Branch of Russian Medical Academy of Continuing Professional Education, Health Ministry of Russian Federation; Kazan (Volga Region) Federal University
2 shared publications - A. L. Mirolyubov
Kazan (Volga Region) Federal University
1 shared publication - A. M. Khromova
Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan
1 shared publication - A. T. Khaertdinov
Kazan (Volga Region) Federal University
1 shared publication - Ainagul Zholdoshevna Bayalieva
Kazan State Medical University
1 shared publication - Airat F. Khalirakhmanov
Medical and Sanitary Unit, Kazan (Volga Region) Federal University; Kazan (Volga Region) Federal University
1 shared publication
Latest Publications
- Open Access
- 7 March 2022
- Published by IRBIS in Obstetrics, Gynecology and Reproduction
- Vol. 16 (1) , 81-89
Umbilical cord vascular thrombosis: literature review and two clinical cases
Thrombosis of the umbilical cord vessels is a rare complication of pregnancy, combined with a high level of perinatal morbidity and mortality. Anomalies of vascular attachment (velamentous attachment), pathology of the umbilical cord (hyperspiralization, short or long umbilical cord), intrauterine infections, maternal diabetes mellitus and preeclampsia as well as meconium found in the amniotic fluid are among the risk factors of developing thrombosis in the umbilical cord vessels. Here we present two clinical observations of umbilical vein thrombosis at full-term pregnancy. In both cases, during pregnancy and childbirth, no signs of umbilical cord pathology were found according to cardiotocography and Doppler ultrasound; despite this, the children were born in hypoxic state. Both newborns were transferred to the second stage of treatment due to suspected intrauterine pneumonia. Velamentous attachment, intrauterine infections as well as meconium found in the amniotic fluid were the risk factors of developing umbilical vein thrombosis described in case 1 and case 2, respectively. During pregnancy, both female patients suffered from clinically confirmed novel coronavirus infection (COVID-19) and contacted patients with COVID-19 in the third trimester of gestation. It is likely that endothelial damage caused by the novel coronavirus SARS-CoV-2 was one of the risk factors for the development of umbilical vein thrombosis, but this issue requires to be further explored.
- 7 March 2022
- Published by IRBIS in Obstetrics, Gynecology and Reproduction
- Vol. 16 (1) , 81-89
Open AccessUmbilical cord vascular thrombosis: literature review and two clinical cases
Thrombosis of the umbilical cord vessels is a rare complication of pregnancy, combined with a high level of perinatal morbidity and mortality. Anomalies of vascular attachment (velamentous attachment), pathology of the umbilical cord (hyperspiralization, short or long umbilical cord), intrauterine infections, maternal diabetes mellitus and preeclampsia as well as meconium found in the amniotic fluid are among the risk factors of developing thrombosis in the umbilical cord vessels. Here we present two clinical observations of umbilical vein thrombosis at full-term pregnancy. In both cases, during pregnancy and childbirth, no signs of umbilical cord pathology were found according to cardiotocography and Doppler ultrasound; despite this, the children were born in hypoxic state. Both newborns were transferred to the second stage of treatment due to suspected intrauterine pneumonia. Velamentous attachment, intrauterine infections as well as meconium found in the amniotic fluid were the risk factors of developing umbilical vein thrombosis described in case 1 and case 2, respectively. During pregnancy, both female patients suffered from clinically confirmed novel coronavirus infection (COVID-19) and contacted patients with COVID-19 in the third trimester of gestation. It is likely that endothelial damage caused by the novel coronavirus SARS-CoV-2 was one of the risk factors for the development of umbilical vein thrombosis, but this issue requires to be further explored.
- Open Access
- 23 July 2021
- Published by Luchevaya Diagnostika in Journal of radiology and nuclear medicine
- Vol. 102 (3) , 172-177
Endovascular Embolization of the Uterine Arteries in Giant Uterine Fibroids
Choosing a treatment option for uterine fibroids is today one of the most relevant problems in gynecological practice. Thanks to the success of modern medicine and the increased level of the population’s culture, female patients seek medical help without waiting for the tumor to acquire significant sizes. However, in practice, there are cases when fibroids reach gigantic sizes. Hysterectomy is a traditional approach to treating uterine fibroids of these sizes according to the current clinical guidelines. The introduction of new high-tech treatments, such as uterine artery embolization, has led to a revision of radical surgery, by giving preference to alternative approaches especially in cases where the patient desires to preserve the reproductive organ. The paper describes a clinical case that confirms an individual approach to choosing a treatment option towards organ-sparing surgery for giant uterine fibroids. The use of endovascular embolization of the uterine arteries as a treatment for giant uterine fibroids is shown to be justified as an organ-sparing surgery if the patient desires to preserve reproductive function.
- 23 July 2021
- Published by Luchevaya Diagnostika in Journal of radiology and nuclear medicine
- Vol. 102 (3) , 172-177
Open AccessEndovascular Embolization of the Uterine Arteries in Giant Uterine Fibroids
Choosing a treatment option for uterine fibroids is today one of the most relevant problems in gynecological practice. Thanks to the success of modern medicine and the increased level of the population’s culture, female patients seek medical help without waiting for the tumor to acquire significant sizes. However, in practice, there are cases when fibroids reach gigantic sizes. Hysterectomy is a traditional approach to treating uterine fibroids of these sizes according to the current clinical guidelines. The introduction of new high-tech treatments, such as uterine artery embolization, has led to a revision of radical surgery, by giving preference to alternative approaches especially in cases where the patient desires to preserve the reproductive organ. The paper describes a clinical case that confirms an individual approach to choosing a treatment option towards organ-sparing surgery for giant uterine fibroids. The use of endovascular embolization of the uterine arteries as a treatment for giant uterine fibroids is shown to be justified as an organ-sparing surgery if the patient desires to preserve reproductive function.
- Open Access
- 9 July 2021
- Published by IRBIS in Obstetrics, Gynecology and Reproduction
- Vol. 15 (3) , 321-329
Clinical observation of severe novel coronavirus infection COVID-19 that complicated the postpartum period in puerpera after caesarean section
The article presents a clinical case of a severe course of a novel coronavirus infection (COVID-19) that complicated the postpartum period in a patient who underwent cesarean section and resulted in lethal outcome on day 43 after delivery. This observation demonstrates the variety of clinical manifestations of a novel coronavirus infection, masking a severe systemic intravascular catastrophe in a puerperal woman.
- 9 July 2021
- Published by IRBIS in Obstetrics, Gynecology and Reproduction
- Vol. 15 (3) , 321-329
Open AccessClinical observation of severe novel coronavirus infection COVID-19 that complicated the postpartum period in puerpera after caesarean section
The article presents a clinical case of a severe course of a novel coronavirus infection (COVID-19) that complicated the postpartum period in a patient who underwent cesarean section and resulted in lethal outcome on day 43 after delivery. This observation demonstrates the variety of clinical manifestations of a novel coronavirus infection, masking a severe systemic intravascular catastrophe in a puerperal woman.